Invesaro

Stocks MNDR Financial statements

Financial statements

Mobile-health Network Solutions financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Mobile-health Network Solutions files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2022FY2024FY2024FY2025
Revenue6.997.87147.65
Cost of revenue5.056.7811.46.37
Gross profit1.941.092.541.28
Selling, general and administrative0.621.94.932.67
Operating expenses1.744.3818.24.83
Other non-operating income0.060.080.080.16
Pre-tax income0.26-3.21-15.6-3.38
Income tax0.17-0.02
Net income0.09-3.21-15.6-3.38
EPS, basic0.39-5.04-18.09-3.82
EPS, diluted0.39-5.04-18.09-3.82
Shares, basic (weighted)0.560.640.860.89
Shares, diluted (weighted)0.560.640.860.89

Balance sheet

FY2022FY2024FY2024FY2025
Cash and equivalents2.236.711.03
Receivables0.070.110.11
Inventory0.150.160.1
Other current assets0.160.220.38
Total current assets2.727.291.78
Property, plant and equipment0.180.220.14
Lease right-of-use assets0.390.370.16
Intangible assets0.070.022.36
Other non-current assets0.080.06
Total assets10.83.447.954.45
Accounts payable1.361.670.87
Total current liabilities2.53.161.69
Lease liabilities0.240.14
Total liabilities3.813.811.83
Paid-in capital8.528.530.2
Retained earnings-9.15-24.8-28.1
Other comprehensive income0.290.430.59
Shareholders' equity-0.374.142.62
Total equity8.44-0.374.142.62
Total liabilities and equity3.447.954.45

Cash flow statement

FY2022FY2024FY2024FY2025
Net income0.09-3.21-15.6-3.38
Depreciation and amortization0.090.090.150.17
Stock-based compensation9.120.41
Deferred income tax0
Change in receivables0.12-0-0.04-0
Change in inventory0.02-0.09-0.020.08
Cash from operations0.98-2.25-6.41-4.36
Capital expenditures-0.02-0.19-0.13-0.06
Cash from investing-0.02-0.19-0.13-2.44
Stock issued9.710.8410.90.98
Share buybacks-6.6
Cash from financing9.23-5.810.90.96
Net change in cash10.1-8.024.48-5.67
Free cash flow0.96-2.43-6.54-4.42
Income taxes paid0.22

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.96 on November 11, 2026.

Profitability

MetricValueHow it is calculated
Gross margin16.7%Gross profit / revenue.
Pre-tax margin-44.3%Pre-tax income / revenue.
Net margin-44.3%Net income / revenue.
FCF margin-57.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-57.0%Cash from operations / revenue.
Return on equity (ROE)-100.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-54.6%Net income / average total assets.
SG&A / revenue34.9%Selling, general and administrative expense / revenue.
Stock-based pay / revenue5.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.8%Capital expenditures / revenue.
D&A / revenue2.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-45.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y-49.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-12.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y-36.8%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-44.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-25.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y2.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y16.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.06xCurrent assets / current liabilities.
Quick ratio0.68x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.61x(Cash + short-term investments) / current liabilities.
Liabilities / assets41.2%Total liabilities / total assets.
Working capital$93.4KCurrent assets - current liabilities.
Goodwill and intangibles / assets53.1%(Goodwill + intangible assets) / total assets.
Tangible book value$255.8KShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.23xRevenue / average total assets.
Fixed asset turnover43.1xRevenue / average property, plant and equipment.
Inventory turnover47.5xCost of revenue / average inventory.
Days inventory8 days365 x average inventory / cost of revenue.
Receivables turnover69.5xRevenue / average receivables.
Days sales outstanding5 days365 x average receivables / revenue.
Days payables73 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-60 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.82Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$3.82Net income per basic share, as reported (split-adjusted).
Revenue per share$8.63Revenue / diluted weighted shares.
FCF per share-$4.99Free cash flow / diluted weighted shares.
Operating cash flow per share-$4.92Cash from operations / diluted weighted shares.
Book value per share$2.95Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.29Tangible book value / shares outstanding.
Cash per share$1.17(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.2MShare price x shares outstanding.
Enterprise value$117.3KMarket cap + total debt - cash - short-term investments.
P/S0.15xMarket cap / revenue.
P/B0.44xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.50xMarket cap / tangible book value, when positive.
EV/Sales0.02xEnterprise value / revenue.
FCF yield-384.1%Free cash flow / market cap.
Earnings yield-293.9%Net income / market cap (the inverse of P/E).
What was Mobile-health Network Solutions's revenue in fiscal 2025?

Mobile-health Network Solutions reported revenue of $7.6M for fiscal 2025, 45.3% lower than the year before.

Was Mobile-health Network Solutions profitable in fiscal 2025?

No. It reported a net loss of $3.4M.

How much free cash flow did Mobile-health Network Solutions generate in fiscal 2025?

Cash from operations of $4.4M minus capital expenditures of $63.1K left free cash flow of -$4.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Mobile-health Network Solutions